QHSLab, Inc. (E1Z.SG)
| Previous close | 0.2240 |
| Open | 0.2640 |
| Bid | 0.2120 x N/A |
| Ask | 0.2500 x N/A |
| Day's range | 0.2240 - 0.2640 |
| 52-week range | 0.2240 - 0.2640 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 2.162M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireQHSLab, Inc. Enhances Leadership Team with Dr. Marcos Sanchez-Gonzalez as New VP of Medical and Scientific Affairs
WEST PALM BEACH, FL, May 02, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the "Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proactive, value-based healthcare solutions, today announced the appointment of Dr. Marcos Sanchez-Gonzalez as the new Vice President of Medical and Scientific Affairs. Strategic Role and Objectives: In his new role, Dr. Sanchez-Gonzalez will spearhead the development, management, and execution of comprehen
- GlobeNewswire
QHSLab, Inc. Announces Preliminary Unaudited First Quarter Revenue Results
WEST PALM BEACH, FL, April 26, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. ("the Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proactive, value-based healthcare solutions, today announced its preliminary unaudited revenue for the first quarter ended March 31, 2024. Financial Highlights: ●First Quarter Revenues were $488,587, a 38% increase over the $352,799 reported in the first quarter of 2023. ●First Quarter Gross Profit was $2
- GlobeNewswire
QHSLab Announces Impressive 2023 Fiscal Year Results with Growing Revenues, Improved Gross Margins, and Substantial Reduction in Net Loss
WEST PALM BEACH, FL, March 28, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the “Company”) (OTCQB: USAQ), a company focused on providing clinicians with tools to leverage proactive, value-based healthcare solutions through emerging digital health and point-of-care technologies, today reported its financial and operational results for the fiscal year ended December 31, 2023. The year was marked by robust revenue growth, significant improvements in gross margins, and a strategic focus on expanding produ
